Cole Werble
In the current new drug approval climate maybe even an "approvable" letter from the Food & Drug Administration is a...
When Approvable Is Good News: Forest Gets January Launch for Bystolic
Is there a way out of the woods for new drug sponsors seeking FDA approval for products with broad primary care indications? Forest may have found a path with nebivolol, but the formula is not one that will excite many other drug sponsors.